Pathway Financial Advisors LLC Baxter International Inc Transaction History

Pathway Financial Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$76.85 - $89.45 $179,982 - $209,491	-2,342 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$74.57 - $87.19 $174,642 - $204,198	2,342 New	2,342 $200,000
Q3 2020 Oct 29, 2020	SELL	$78.33 - $90.73 $183,448 - $212,489	-2,342 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$78.66 - $94.14 $184,221 - $220,475	2,342 New	2,342 $202,000
Q1 2020 Apr 21, 2020	SELL	$71.57 - $93.3 $167,616 - $218,508	-2,342 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$76.7 - $88.45 $179,631 - $207,149	2,342 New	2,342 $213,000
Q3 2018 Jan 16, 2019	SELL	$70.71 - $77.75 $165,602 - $182,090	-2,342 Closed	0 $0
Q4 2017 May 04, 2018	BUY	$61.45 - $66.05 $143,915 - $154,689	2,342	2,342 $151,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pathway Financial Advisors LLC with notifications on news.